Atenolol clinical indications
Pro Research Analysisby 
Searched over 200M research papers
Atenolol Clinical Indications in Hypertension
Atenolol is widely used to treat hypertension (high blood pressure) and is effective across all grades of hypertension, including in elderly patients and women with pregnancy-associated hypertension. It lowers blood pressure to a similar extent as other beta-blockers, ACE inhibitors, and calcium channel blockers, and is generally well tolerated with a favorable side effect profile compared to some alternatives 1235. Atenolol is also considered to have theoretical advantages over other beta-blockers due to its cardioselectivity . However, in elderly patients, atenolol may be associated with a slightly increased risk of stroke compared to other antihypertensive agents, while in younger patients, it is effective in reducing cardiovascular events .
Atenolol for Angina Pectoris and Myocardial Infarction
Atenolol is effective in managing stable angina pectoris, reducing the frequency of anginal attacks, and improving exercise tolerance. It is also used to reduce recurrence of myocardial infarction and lower cardiovascular mortality when started early after a heart attack and continued as maintenance therapy 135. Its safety and efficacy in these settings make it a well-established option in cardiovascular medicine 15.
Atenolol in Cardiac Arrhythmias
Atenolol is used to prevent the recurrence of supraventricular arrhythmias, especially after initial control is achieved with intravenous administration. Its beta-1 selectivity makes it suitable for patients who require heart rate control without significant central nervous system side effects 15.
Atenolol in Alcohol Withdrawal Syndrome
Atenolol has been shown to be helpful in managing symptoms of alcohol withdrawal syndrome. It reduces the need for benzodiazepines, shortens hospital stays, and helps normalize vital signs and resolve abnormal behaviors more rapidly than placebo .
Atenolol for Infantile Hemangiomas
Atenolol is an effective alternative to propranolol for treating infantile hemangiomas, with similar efficacy but fewer severe side effects. This makes it a promising option for pediatric patients, although further randomized clinical trials are needed to confirm its safety and effectiveness .
Metabolic and Hemodynamic Considerations
Atenolol can reduce insulin sensitivity and glucose tolerance in hypertensive patients, which may be a consideration for those with impaired glucose metabolism. Despite this, it effectively lowers blood pressure and heart rate, with a lower incidence of central nervous system side effects due to its low lipid solubility 18. Its pharmacokinetics allow for once-daily dosing, and it is generally well tolerated 610.
Conclusion
Atenolol is a well-established, cardioselective beta-blocker with proven efficacy in treating hypertension, angina pectoris, cardiac arrhythmias, and for secondary prevention after myocardial infarction. It is also useful in managing alcohol withdrawal and infantile hemangiomas. While generally safe and well tolerated, clinicians should consider its metabolic effects and the slightly increased risk of stroke in elderly hypertensive patients when choosing therapy.
Sources and full results
Most relevant research papers on this topic